InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,562.05
(
0.96%
)
US TECH 100
19,824.40
(
0.93%
)
Dow Jones
39,362.91
(
0.14%
)
Brent Oil
86.44
(
-1.02%
)
Bitcoin
56,521.48
(
-0.81%
)
Post# of 38376
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

damsam1

Send PM Follow Ignore
Followers 7
Posts 334
Boards Moderated 0
Alias Born 06/03/2012

damsam1

Re: JokersWild12 post# 11781

Saturday, 09/01/2012 2:22:59 PM

Saturday, September 01, 2012 2:22:59 PM

Post# of 38376
The buisness model described here is absolutely! brilliant. The data collected over time is highly valuble when imenvax becomes a consideration for cancer therapy for humans. The intellectual value of Imenvax "alone" for entest in my opinion is worth a 50 million market cap before any revenue. That would currently price the stock if fully diluted at $0.05 cents.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up